Europe Generic Injectables Market to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Generic Injectables Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Generic Injectables Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in generic drug production and sales
5.1.2 Rising demand for generic injectables in the pharmaceutical industry

5.2 Market Opportunities

5.2.1 Growth in generic drug demand globally
5.2.2 Expanding opportunities for generic injectables in emerging pharmaceutical markets

5.3 Future Trends

5.3.1 Growth in the demand for cost-effective medications
5.3.2 availability of biosimilar and generic injectables
5.3.3 Rising demand in chronic disease treatments.

5.4 Impact of Drivers and Restraints

6. Europe Generic Injectables Market Regional Analysis

6.1 Europe Generic Injectables Market Overview

6.2 Europe Generic Injectables Market Revenue 2019-2028 (US$ Million)

6.3 Europe Generic Injectables Market Forecast Analysis

7. Europe Generic Injectables Market Analysis – by Product Type

7.1 Large Molecule Injectables

7.1.1 Overview
7.1.2 Large Molecule Injectables: Europe Generic Injectables Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Small Molecule Injectables

7.2.1 Overview
7.2.2 Small Molecule Injectables: Europe Generic Injectables Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Generic Injectables Market Analysis – by Container Type

8.1 Vials

8.1.1 Overview
8.1.2 Vials: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Premix

8.2.1 Overview
8.2.2 Premix: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Prefilled Syringes

8.3.1 Overview
8.3.2 Prefilled Syringes: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Ampoules

8.4.1 Overview
8.4.2 Ampoules: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Generic Injectables Market Analysis – by Application

9.1 Oncology

9.1.1 Overview
9.1.2 Ampoules: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Infectious Diseases

9.2.1 Overview
9.2.2 Ampoules: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Cardiology

9.3.1 Overview
9.3.2 Ampoules: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diabetes

9.4.1 Overview
9.4.2 Ampoules: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Immunology

9.5.1 Overview
9.5.2 Ampoules: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Generic Injectables Market – Europe Analysis

10.1 Europe

10.1.1 Europe Generic Injectables Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Generic Injectables Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Generic Injectables Market Breakdown, by Product Type
10.1.1.1.2 UK: Europe Generic Injectables Market Breakdown, by Container Type
10.1.1.1.3 UK: Europe Generic Injectables Market Breakdown, by Application

10.1.1.2 Germany: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Generic Injectables Market Breakdown, by Product Type
10.1.1.2.2 Germany: Europe Generic Injectables Market Breakdown, by Container Type
10.1.1.2.3 Germany: Europe Generic Injectables Market Breakdown, by Application

10.1.1.3 France: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Generic Injectables Market Breakdown, by Product Type
10.1.1.3.2 France: Europe Generic Injectables Market Breakdown, by Container Type
10.1.1.3.3 France: Europe Generic Injectables Market Breakdown, by Application

10.1.1.4 Russia: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Generic Injectables Market Breakdown, by Product Type
10.1.1.4.2 Russia: Europe Generic Injectables Market Breakdown, by Container Type
10.1.1.4.3 Russia: Europe Generic Injectables Market Breakdown, by Application

10.1.1.5 Italy: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Generic Injectables Market Breakdown, by Product Type
10.1.1.5.2 Italy: Europe Generic Injectables Market Breakdown, by Container Type
10.1.1.5.3 Italy: Europe Generic Injectables Market Breakdown, by Application

10.1.1.6 Rest of Europe: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Generic Injectables Market Breakdown, by Product Type
10.1.1.6.2 Rest of Europe: Europe Generic Injectables Market Breakdown, by Container Type
10.1.1.6.3 Rest of Europe: Europe Generic Injectables Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Generic Injectables Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Baxter International Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Biocon

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Fresenius SE & Co. KGaA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 GlaxoSmithKline plc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Hikma Pharmaceuticals PLC

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Johnson and Johnson Services, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Lupin

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Merck & Co., Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Pfizer Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Viatris Inc

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights